Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery Letter

Lassman, Andrew B, Polley, Mei-Yin C, Iwamoto, Fabio M et al. (2026). Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery . JOURNAL OF CLINICAL ONCOLOGY, 44(13), 1267-1268. 10.1200/JCO-25-02821

cited authors

  • Lassman, Andrew B; Polley, Mei-Yin C; Iwamoto, Fabio M; Gondi, Vinai; Sulman, Erik P; Wolchok, Jedd D; Mehta, Minesh P

authors

publication date

  • May 1, 2026

published in

keywords

  • BEVACIZUMAB
  • Life Sciences & Biomedicine
  • Oncology
  • RADIOTHERAPY
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 1267

end page

  • 1268

volume

  • 44

issue

  • 13